UC San Diego Theoretical Physicist Max Di Ventra is catching the next wave of cutting-edge AI with an alternative platform he calls “memcomputing,” which doesn’t require quantum capabilities.
J. Silvio Gutkind elected to National Academy of Medicine for his contributions to the understanding of cancer signaling networks and pioneering the study of the PIK3CA-mTOR signaling circuitry in head and neck cancer.
New Precision Immunotherapy Therapy clinic at Moores Cancer Center at UC San Diego Health matches patients using genetic profiling to personalized cancer treatment plans.
In fiscal year 2019, UC San Diego earned $1.35 billion in sponsored research funding, a 10% increase over the previous year. This is the largest number ever for the university and marks the 10th consecutive year the campus has surpassed the $1 billion mark.
Material scientists have discovered what makes the scales of the massive Amazonian freshwater fish, Arapaima gigas, resistant to breaking when a piranha bites. The answer could serve as inspiration for stronger, lightweight and flexible synthetic armors.
UC San Diego bioengineers are a step closer to making CAR T-cell therapy safer, more precise and easy to control. They developed a system that allows them to select where and when CAR T cells get turned on so that they destroy cancer cells without harming normal cells.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
